Multi-Antiviral Resistance clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab
open to eligible people ages 18 years and up
The virological efficacy of ibalizumab has been clearly demonstrated in multiple clinical trials. This study will expand ibalizumab's clinical data set and allow a better understanding of the virologic response durability on ARV regimens with or…
at UCSD
Our lead scientists for Multi-Antiviral Resistance research studies include Nimish Patel, MD.
Last updated: